RESUMEN
BackgroundQuality of life， as a major criterion for judging the clinical outcome of ovarian cancer patients， can be affected by adverse psychological symptoms of patients. Meanwhile， fear of disease progression， as a frequent psychological symptom among cancer survivors， is significantly influenced by metacognition， while there is a paucity of research into the specific correlation among the three in patients with ovarian cancer. ObjectiveTo explore the correlation among fear of disease progression， metacognition and quality of life in patients with ovarian cancer， and to test the role of fear of disease progression in the relationship between metacognition and quality of life， so as to provide references for improving the quality of life in patients with ovarian cancer. MethodsA total of 135 patients with ovarian cancer hospitalized in Cangzhou People's Hospital of Hebei Province from January 2019 to December 2022 were selected. All subjects were requested to complete the Functional Assessment of Cancer Therapy-Ovarian Cancer （FACT-O）， Fear of Progression Questionnaire-Short Form （FoP-Q-SF） and Metacognition Questionnaire （MCQ） to assess their quality of life， fear of disease progression and metacognitive level. Pearson correlation analysis was adopted to examine the correlation among the above scales. Process v3.5 macro program was utilized to determine the mediating effect of fear of disease progression on the relationship between metacognition and quality of life， and nonparametric Bootstrap with bias-correction was used to test the mediating effect. ResultsA total of 122 patients （90.37%） with ovarian cancer completed the effective questionnaire survey. Patients scored （90.52±17.13） on FACT-O， （68.52±16.31） on MCQ， and （37.72±8.91） on FoP-Q-SF. Pearson correlation analysis denoted that FoP-Q-SF score was negatively correlated with FACT-O score （r=-0.412， P<0.05） and positively correlated with MCQ score （r=0.241， P<0.05）， and MCQ score was negatively correlated with FACT-O score （r=-0.453， P<0.05）. Analysis demonstrated that the total effect of metacognition on quality of life was -0.298 （95% CI： -0.402~-0.186）. The direct effect of metacognition on quality of life was -0.219 （95% CI： -0.504~-0.277）， accounting for 73.49% of the total effect， and the indirect effect of metacognition on quality of life via fear of disease progression was -0.079 （95% CI： -0.162~-0.037）， accounting for 26.51% of the total effect. ConclusionQuality of life is reduced in patients with ovarian cancer， and fear of disease progression plays a partial mediating role in the relationship between metacognition and quality of life.
RESUMEN
Introducción: La ansiedad por la salud es un estado psicológico caracterizado por cierto tipo de creencias, emociones y actitudes hacia la posibilidad de contraer una enfermedad. La ansiedad por la salud ha sido considerada un mediador de la respuesta psicológica ante la pandemia generada por el COVID-19. Objetivo: Determinar el nivel de ansiedad por la salud de una muestra de estudiantes universitarios colombianos, discriminando y comparando en función de ciertas variables sociodemográficas, y describir sus principales características durante el confinamiento social en el segundo semestre del 2020. Metodología: Se realizó un estudio cuantitativo, no experimental, de nivel descriptivo y corte transversal en una muestra de 1004 estudiantes de pregrado de 3 instituciones de educación superior de la ciudad de Medellín. Se utilizó el Inventario Breve de Ansiedad por la Salud. Resultados: El valor de la media para la ansiedad por la salud estuvo por encima del valor reportado por otros estudios. Se encontraron altos porcentajes de preocupación por la salud (39,64 %), consciencia del malestar/dolor (63,3 %), miedo de tener una enfermedad grave (20,01 %), interés por las sensaciones o cambios corporales (68,92 %), riesgo de padecer una enfermedad grave (30,33 %) y consecuencias sobre la vida (35,75 %). No se encontraron diferencias estadísticamente significativas en ninguna de las comparaciones entre grupos. Conclusiones: La preocupación por la salud y la ansiedad durante las epidemias/pandemias pueden tener un impacto psicológico importante, además de estar relacionadas con un comportamiento preventivo ineficaz y tener consecuencias adversas en el largo plazo.
Introduction: Health anxiety is a psychological state characterized by certain types of beliefs, emotions, and attitudes toward the possibility of contracting a disease. Health anxiety has been considered a mediator of the psychological response to the pandemic generated by COVID-19. Objectives: To determine the level of health anxiety in a sample of Colombian university students, discriminating and comparing according to certain sociodemographic variables, and to describe the main during social confinement between August and November 2020. Methodology: A quantitative, non-experimental, descriptive, cross-sectional study was conducted in a sample of 1004 undergraduate students from three higher education institutions in the city of Medellin. The Short Health Anxiety Inventory - SHAI was used. Results: The mean value for health anxiety was above the value reported by other studies. High percentages of health concern (39.64 %), awareness of discomfort/pain (63.3 %), fear of having a serious illness (20.01 %), interest in bodily sensations or changes (68.92 %), risk of having a serious illness (30.33 %) and consequences on life (35.75 %) were found. No statistically significant differences were found in any of the comparisons between groups. Conclusions: Health concerns and anxiety during with epidemics/pandemics can have a significant psychological impact, as well as being related to ineffective preventive behavior and having adverse long-term consequences.
Asunto(s)
Humanos , Masculino , Femenino , Adulto Joven , Salud Mental , Estudiantes , Coronavirus , COVID-19RESUMEN
Objective:To explore the status quo of young patients′ perception of partner responsiveness and fear of disease progression after surgery of cervical cancer, and to analyze the correlation between the two to provide a basis for targeted intervention.Methods:From October 2018 to June 2020, a convenient sampling method was used to select 121 young patients after radical resection of cervical cancer who were treated in East Branch of Qingdao Municipal Hospital. It was investigated by the Perceived Partner Responsiveness Scale and the Fear of Progression Questionnaire-Short Form in cancer patients.Results:The total score of perceived partner responsiveness of young patients with cervical cancer after surgery was (41.30 ± 6.14) points, and the total score of fear of disease progression was (31.10 ± 6.58) points; perceived partner responsiveness was negatively correlated with fear of disease progression ( r=-0.72, P<0.05). Multiple linear regression analysis showed that work status and perceived partner responsiveness were the influencing factors of patients' fear of disease progression ( t=11.54, 18.40, all P<0.05). Conclusions:The perception of partner responsiveness in young patients with cervical cancer after surgery is closely related to the fear of disease progression. Perception of partner responsiveness can affect patients′ fear of disease progression; it can improve the patients′ perception of partner responsiveness to improve their fear of disease progression.
RESUMEN
Objective:To explore the chain mediating effects of anxiety/depression and metacognition between somatic symptoms and fear of disease progression (FoP) in gynecological tumor patients.Methods:A total of 208 gynecological tumor patients were investigated by general demographic data, fear of progression questionnaire-short form(FoP-Q-SF), hospital anxiety and depression scale(HADS), metacognition questionnaire(MCQ) and somatic symptom scale(SSS). SPSS 25.0 was used for Pearson correlation analysis. The significance of mediating effect was tested by deviation corrected nonparametric percentile Bootstrap method using SPSS macro program PROCESS.Results:The scores of FoP-Q-SF, depression, anxiety, MCQ and SSS were (32.41±10.43), (6.43±4.17), (7.51±4.10), (68.44±16.04), (20.58±15.70) respectively. 48.56% of gynecological tumor patients had dysfunctional fear of disease progression. Correlation analysis showed that FoP was significantly positively correlated with somatic symptoms ( r=0.394, P<0.01), anxiety ( r=0.640, P<0.01), depression ( r=0.533, P<0.01) and metacognition ( r=0.489, P<0.01). Mediating effect test showed that anxiety, depression and metacognition played a complete chain mediating role between somatic symptoms and FoP in gynecological tumor patients.The total effect of somatic symptoms on FoP was 0.320. Somatic symptoms indirectly affected FoP by influencing anxiety and metacognition, and the intermediary effect value was 0.242. Somatic symptoms indirectly affected FoP by influencing depression and metacognition, and the intermediary effect value was 0.212. Conclusion:Somatic symptoms can indirectly affect FoP through the chain mediation of anxiety/depression and metacognition.
RESUMEN
Objective:To investigate the effects of meditation therapy on fear of disease progress and mental health among acute myocardial infarction (AMI) patients.Methods:Totally, 120 cases of acute myocardial infarction patients admitted to Affiliated Hospital of Jiangnan University were divided into experimental group and control group according to the enrolled time. 60 patients with AMI treated from June to November 2018 served as the control group and 60 patients with AMI treated from January to May 2019 served as the experimental group. The patients in the control group received routine nursing, the experimental group carried out 4-week meditation therapy based on the routine nursing. Before and after intervention, the effect was assessed by Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and Symptom Checklist-90 (SCL-90), respectively.Results:After intervention, the physical health and social family function dimension scores in FoP-Q-SF as well as total FoP-Q-SF scores were (12.78±3.47), (10.45±2.44), (23.24±4.25) points, significantly lower than in the control group (14.33±2.72), (11.59±2.82), (25.91±3.89) points, the difference was statistically significant ( t values were 2.623, 2.277, 3.499, P<0.05); the scores of somatization, compulsion, anxiety, depression and total SCL-90 were (1.26±0.19), (1.42±0.23), (1.19±0.28), (1.20±0.16) and (121.81±9.59) points, significantly lower than (1.83±0.25), (1.68±0.37), (1.82±0.41), (1.71±0.33) and (145.85±9.12) points in the control group, the difference was statistically significant ( t values were from 4.580 to 13.659, P<0.001). Conclusion:Meditation therapy can effectively decrease disease progress and promote mental health in patients with acute myocardial infarction.
RESUMEN
Objective:To explore the relationship between cardiac discomfort symptoms, fear of disease progress and post-traumatic stress disorder (PTSD) in patients with acute myocardial infarction(AMI) after discharge, and to clarify main intervention direction of PTSD in patients with AMI.Methods:Patients with AMI who were discharged from Tangshan Gongren Hospital between 1 month and 1 year were selected from November 2019 to November 2020.The cardiac discomfort symptoms scale, fear of progress questionnaire(FoP-Q-SF) and post-traumatic stress disorder self-rating scale(PTSD-SS) were used to investigate cardiac discomfort symptoms, fear of disease progress level and post-traumatic stress disorder status.Spearman rank correlation analysis was used to analyze the relationship between cardiac discomfort symptoms, fear of disease progress and post-traumatic stress disorder by SPSS 24.0 software. The mediating effect of fear of disease progress was analyzed by AMOS 24.0 software.Results:The PTSD score was (32.78±12.38) of patients with AMI discharged from hospital for 1 month to 1 year and the incidence of PTSD was 12.3%.Spearman correlation test showed cardiac discomfort symptoms and fear of disease progress were positively correlated with PTSD( r=0.530, 0.723, both P<0.01) and cardiac discomfort symptoms was positively correlated with fear of disease progress( r=0.518, P<0.01). Mediating effect test showed that fear of disease progress was a complete mediator between cardiac discomfort symptoms and PTSD. Conclusion:Cardiac discomfort symptoms can affect PTSD through a complete mediator of fear of disease progress.